Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(3 sites)
United States
University of California San Francisco, San Francisco, California Children's Hospital Colorado, Aurora, Colorado Mayo Clinic, Rochester, Minnesota Last updated December 2024
Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age — Stella